XLerateHealth, UK awarded first phase of $3.25M grant supporting commercialization

The funding will help develop and launch a suite of experience-based entrepreneurship and commercialization training tools to address the needs of academic institutions across the Southeast U.S.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news